| Apr 3 2025 |
Criminal Health Care Fraud Enforcement: Projections for 2025 and Beyond [Podcast] |
Epstein Becker & Green, P.C. |
| Apr 3 2025 |
Court Sides with RICO Complainant Who Received Tainted Medical Marijuana and with FDA on Regulating E-Cigarettes - SCOTUS Today |
Epstein Becker & Green, P.C. |
| Apr 3 2025 |
Tempus Fugit Ad Nevada |
Allen Matkins Leck Gamble Mallory & Natsis LLP |
| Apr 3 2025 |
Wyoming Bans Most Non-Compete Agreements |
Proskauer Rose LLP |
| Apr 2 2025 |
Immigration Enforcement and Healthcare Facilities: Key Considerations for Providers |
Sheppard, Mullin, Richter & Hampton LLP |
| Apr 2 2025 |
VHA and DLA Enter Into Another Interagency Agreement: Déjà Vu All Over Again? |
Blank Rome LLP |
| Apr 2 2025 |
This Week in 340B: March 25 – 31, 2025 |
McDermott Will & Schulte LLP |
| Apr 2 2025 |
Wyoming Enacts Law to Restrict the Use of Noncompete Agreements |
Ogletree, Deakins, Nash, Smoak & Stewart, P.C. |
| Apr 2 2025 |
Updates from the April 2025 New Market Tax Credit (NMTC) Compliance Monitoring FAQs |
Polsinelli PC |
| Apr 2 2025 |
March 2025 PFAS Legislative Developments |
CMBG3 Law |
| Apr 2 2025 |
Texas Court Vacates FDA’s Laboratory Developed Test (LDT) Final Rule |
Foley & Lardner LLP |
| Apr 1 2025 |
In Landmark Ruling, Eastern District of Texas Strikes Down FDA’s Final Rule Regulating Laboratory Developed Tests |
Polsinelli PC |
| Apr 1 2025 |
Thompson v. United States (No. 23-1095) |
Wiggin and Dana LLP |
| Apr 1 2025 |
Reproductive Health Under Trump: What’s New and What’s Next |
McDermott Will & Schulte LLP |
| Apr 1 2025 |
HUD’s Enforcement of the Violence Against Women Act: What Housing Providers Should Know |
Wilson Elser Moskowitz Edelman & Dicker LLP |
| Apr 1 2025 |
A Final Rule Bites the Dust: Federal Court Rules FDA Lacks Authority to Regulate LDTs |
Epstein Becker & Green, P.C. |
| Apr 1 2025 |
We Never Know How High We Are Until We Are Called to Rise: Protecting Alabama’s Medical Cannabis Program |
Bradley Arant Boult Cummings LLP |
| Apr 1 2025 |
FDA Announces “Operation Stork Speed” |
Keller and Heckman LLP |
| Apr 1 2025 |
FDA’s New Transparency Tool Addresses Chemical Contaminants |
Sheppard, Mullin, Richter & Hampton LLP |
| Mar 31 2025 |
Effective Risk Management for Nursing Facilities: Insurance Insights on Retaliation Claims |
Bradley Arant Boult Cummings LLP |
| Mar 31 2025 |
What Would John Wilkes Booth Do? Mandatory COVID Vaxes for Actors |
Proskauer Rose LLP |
| Mar 31 2025 |
Pedestrian Fatalities Up Almost Half from a Decade Ago |
Buckfire Law |
| Mar 28 2025 |
HHS Job Cuts: FDA, CDC, NIH and CMS Impacted Amidst Significant Restructurings |
Polsinelli PC |
| Mar 28 2025 |
Virginia Enacts Law Protecting Reproductive and Sexual Health Data |
Hunton Andrews Kurth |
| Mar 28 2025 |
McDermott+ Check-Up: March 28, 2025 |
McDermott Will & Schulte LLP |
| Mar 28 2025 |
Are the Days of OSHA’s Rulemaking and Reliance on Consensus Standards Numbered? |
Ogletree, Deakins, Nash, Smoak & Stewart, P.C. |
| Mar 27 2025 |
Pennsylvania Teacher’s Union Faces Class Action over Data Breach |
Robinson & Cole LLP |
| Mar 27 2025 |
Joint Bulletin Warns Health Sector of Potential Coordinated Multi-City Attack |
Robinson & Cole LLP |
| Mar 27 2025 |
Behavioral Health Law Ledger | March 2025 |
Greenberg Traurig, LLP |
| Mar 27 2025 |
THE WHITE COAT DIDN’T BETRAY YOU—THE PIXEL DID: Judge Keeps Florida Wiretap Case Against Hospital Alive |
Troutman Amin, LLP |
| Mar 27 2025 |
Massachusetts: Expansion of Oversight Authority — New Notice of Material Change Form for Health Care Transactions |
Foley & Lardner LLP |
| Mar 27 2025 |
Even Jepson Preambles Require Written Description Support |
McDermott Will & Schulte LLP |
| Mar 26 2025 |
This Week in 340B: March 18 – 24, 2025 |
McDermott Will & Schulte LLP |
| Mar 26 2025 |
The Trump Administration Proposes Changes to Regulations Governing Insurance Subject to the Affordable Care Act |
Squire Patton Boggs (US) LLP |
| Mar 26 2025 |
2026 Medicare Advantage and Part D Final Rate Notice: What to Expect |
McDermott Will & Schulte LLP |
